About Stability Biologics
Stability Biologics is a company based in Nashville (United States) founded in 2010 was acquired by MiMedx Group in January 2016.. Stability Biologics offers products and services including AmnioCore, AmnioCore Surgical, AmnioCore Burn, Cortical Fibers, and Cancellous Chips. Stability Biologics operates in a competitive market with competitors including GSK, Avidity Biosciences, Humacyte, Vividion Therapeutics and Korro Bio, among others.
- Headquarter Nashville, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Stability Biologics, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
MiMedx Group
(Jan 10, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Stability Biologics
Stability Biologics offers a comprehensive portfolio of products and services, including AmnioCore, AmnioCore Surgical, AmnioCore Burn, Cortical Fibers, and Cancellous Chips. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Advanced allograft for regenerative medicine and tissue repair applications.
Specialized allograft for surgical wound healing and patient care.
Allograft designed for burn treatment and skin regeneration processes.
Material for bone grafting in medical and regenerative procedures.
Chips used for bone repair and structural support in surgeries.
Funding Insights of Stability Biologics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Stability Biologics
Stability Biologics has secured backing from 1 investor. Prominent investors backing the company include MiMedx Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Stability Biologics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Stability Biologics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Stability Biologics Comparisons
Competitors of Stability Biologics
Stability Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Humacyte, Vividion Therapeutics and Korro Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Human tissue-based products are developed for vascular disease applications.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Stability Biologics
When was Stability Biologics founded?
Stability Biologics was founded in 2010.
Where is Stability Biologics located?
Stability Biologics is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.
What does Stability Biologics do?
Founded in 2010 in Nashville, United States, Stability Biologics operates in the tissue engineering sector. Bone tissue and demineralized bone matrix are manufactured for grafting procedures, alongside split-thickness skin grafts for burn treatment and traditional allograft cancellous bone products. Operations began as an FDA-registered tissue bank, with a merger to MiMedx occurring in 2016 to expand biomaterials capabilities.
Who are the top competitors of Stability Biologics?
Stability Biologics's top competitors include Sutro Biopharma, Synthego and Humacyte.
What products or services does Stability Biologics offer?
Stability Biologics offers AmnioCore, AmnioCore Surgical, AmnioCore Burn, Cortical Fibers, and Cancellous Chips.
Who are Stability Biologics's investors?
Stability Biologics has 1 investor. Key investors include MiMedx Group.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.